Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Clinical trial NCT02207634 · COMPLETED
Trial details
- NCT number
- NCT02207634
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-10
- Primary completion
- 2016-11-11
- Enrollment
- 1974
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.